Article

Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments

2022-01-28

Abstract excerpt

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Because current treatment regimens show limited success rates, alternative therapeutic approaches are needed. We recently showed that treatment-naive, stage I/II primary NSCLC tumors contain a high percentage of tumor-reactive T cells, and that these tumor-reactive T cells can be effectively expanded and used for the gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc44c8d3-aea6-5aeb-9e21-c081608bedf3
DOI: 10.1101/2022.01.28.478173

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatmentsDOI 10.1101/2022.01.28.478173Read

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profileSemantic proximity Read

Phenotypic analysis of tumor-infiltrating lymphocytes from non-small cell lung cancer and their potential application for adoptive cell therapy.Semantic proximity Read

Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets.Semantic proximity Read

Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL productsSemantic proximity Read

Immune characteristics associated with lymph node metastasis in early-stage NSCLCSemantic proximity Read

CD4 <sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsSemantic proximity Read

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapySemantic proximity Read

CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsSemantic proximity Read

Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.Semantic proximity Read

Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resectionSemantic proximity Read

Lung-targeted cytokine-coding RNA-lipoplexes induce T and NK cell-mediated anti-tumor immune responseSemantic proximity Read

CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignanciesSemantic proximity Read